-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
As we all know, probiotics are important micro-ecological regulators, and long-term scientific research has confirmed that they can effectively regulate the human intestinal micro-ecology, and exert corresponding probiotic effects, which are beneficial to the human intestinal tract, immunity, metabolism and other fields. health regulation . In recent years, probiotics have become an important choice for people seeking a healthy life . Choosing local probiotics that are more suitable for Chinese genes and dietary habits can better exert probiotic effects . Status quo of China's probiotics industry: the soil is weak and the ocean is strong. Looking at the development of China's probiotics market for more than 20 years, there are still a series of problems such as a late start compared to foreign countries, weak independent research and development capabilities, and few patented strains; The safety verification and probiotic efficacy of "foreign bacteria" are fully researched, and they were listed in the Chinese market in large quantities earlier, which has resulted in the long-term dependence of the Chinese probiotic market on "foreign bacteria" . Scientific selection of probiotics: similar genotypes are more suitable for this purpose. Scientists have conducted large-scale scientific research, collecting samples from different countries (Korea, Japan, the United States, China), different races (America, Asia, Europe), and different diets. The intestinal flora samples of the habitual population were tested for a series of indicators such as gene expression and metabolic level. The results showed that different countries, ethnic dietary habits, living habits and even differences in metabolic levels all affect the differences in intestinal flora . This shows that there are significant differences in the intestinal flora of different populations, especially different continents and different national populations . There is also a comparative study on the intestinal flora of infants in different countries around the world, and found that there are significant differences in the intestinal flora of infants in different countries in the world. The predominant P, A, and F enterotypes have obvious geographical distribution differences, while Chinese infants are dominated by enterotype P. There are also many types of probiotics, the main types are lactic acid bacteria and bifidobacteria; different types of probiotics have different genotypes, survival, tolerance, probiotic efficacy and adaptation to the population, which means that It is particularly important to select probiotics with similar genotypes and similar adaptations for health intervention . Strain resource protection and development: screening a batch of Chinese strains Strain resources have always been the core of the probiotics industry, and it is also one of the difficult problems for domestic probiotics companies . At present, some probiotic companies in China have made breakthroughs in this regard . As a listed company in China's probiotics industry, Ketuo Biology attaches great importance to the development and utilization of bacterial resources . According to Dr. Wang Jicheng, director of research and development of Ketuo Bio, since its establishment in 2003, Ketuo has cooperated with many domestic universities, research institutes and enterprises to collect natural fermented food, intestinal and breast milk samples from healthy people from all over Asia, and isolate and identify them. And preserved 21268 strains of lactic acid bacteria, and built the largest strain library in Asia . It is not enough to have a strain library, which also requires scientific and accurate screening of the strains in it! Taking Ketuo Biology as an example, under the leadership of Chief Scientist Professor Zhang Heping, we overcame many difficulties and went through a lot of basic research including gene sequencing, safety evaluation, metabolomics analysis, etc. , as well as follow-up animal experiments and clinical trials. After waiting for research, we finally screened out a batch of probiotics from China, and applied for related patents! The most representative patented strains include Lactobacillus casei Zhang, Bifidobacterium lactis V9, Lactobacillus plantarum P-8; Bifidobacterium lactis Probio-M8 and Lactobacillus rhamnosus Probio-M8 from Chinese breast milk samples M9, etc. These precious strain resources not only create value and core competitiveness for enterprises, but also help the sustainable development of China's probiotics industry; under the background of changing lifestyles and declining strain resources, they have also preserved a number of valuable resources for the Chinese people. The bacterial resources of the plant have laid a foundation for the development of more probiotics suitable for Chinese health in the future . What are high-quality probiotics: clinically proven safety and efficacy High-quality probiotics must have undergone rigorous scientific research, including genetic background research, tolerance experiments, safety verification, industrial application evaluation, animal Experimental and most important clinical trial investigations . Ketuo Bio has also taken the lead in the research on probiotic efficacy. At present, the research on star strains has been very detailed, and more than 300 documents have been published and more than 120 invention patents have been applied for . At present, Ketuo Bio has cooperated with more than ten tertiary hospitals in China, and has carried out a total of 60 clinical trials. The clinical effects are remarkable and have won unanimous praise from doctors . In terms of the industrial application of probiotics, Ketuo Bio also attaches great importance to the research on probiotics that are more suitable for the Chinese intestines, and launched the Chinese intestinal system research project to establish the unique intestinal bacteria of the Chinese population. Group database, relying on accurate Chinese people's intestinal flora data, has created a new "Yishiyou" product that better understands the Chinese people's intestines, has provided probiotic product support for more than 1,200 national team athletes, and provided preparations for 13 national teams. . Disclaimer: This article only represents the author's personal opinion and has nothing to do with China Probiotics Network . Its originality and the text and content stated in the text have not been verified by this site, and this site does not make any guarantee or commitment to the authenticity, completeness and timeliness of this text and all or part of its content and text. Readers are only for reference and please Verify the relevant content yourself . Copyright Notice 1. Some articles reproduced on this site are not original, and their copyright and responsibility belong to the original author . 2. All reprinted articles, links and pictures on this website are for the purpose of conveying more information, and the source and author are clearly indicated. Media or individuals who do not wish to be reprinted can contact us for infringing information that can provide sufficient evidence. , bio149 will be deleted within 12 hours after confirmation . 3. Users are welcome to submit original articles to 86371366@qq. com, which will be published on the homepage after review, and the copyright and responsibility of the articles belong to the sender . |
As we all know, probiotics are important micro-ecological regulators, and long-term scientific research has confirmed that they can effectively regulate the human intestinal micro-ecology, and exert corresponding probiotic effects, which are beneficial to the human intestinal tract, immunity, metabolism and other fields.
health regulation
.
In recent years, probiotics have become an important choice for people seeking a healthy life
.
Choosing local probiotics that are more suitable for Chinese genes and dietary habits can better exert probiotic effects
.
Status quo of China's probiotics industry: the soil is weak and the ocean is strong.
Looking at the development of China's probiotics market for more than 20 years, there are still a series of problems such as a late start compared to foreign countries, weak independent research and development capabilities, and few patented strains; The safety verification and probiotic efficacy of "foreign bacteria" are fully researched, and they were listed in the Chinese market in large quantities earlier, which has resulted in the long-term dependence of the Chinese probiotic market on "foreign bacteria"
.
Scientific selection of probiotics: similar genotypes are more suitable
for this purpose.
Scientists have conducted large-scale scientific research, collecting samples from different countries (Korea, Japan, the United States, China), different races (America, Asia, Europe), and different diets.
The intestinal flora samples of the habitual population were tested for a series of indicators such as gene expression and metabolic level.
The results showed that different countries, ethnic dietary habits, living habits and even differences in metabolic levels all affect the differences in intestinal flora
.
This shows that there are significant differences in the intestinal flora of different populations, especially different continents and different national populations
.
There is also a comparative study on the intestinal flora of infants in different countries around the world, and found that there are significant differences in the intestinal flora of infants in different countries in the world.
The predominant P, A, and F enterotypes have obvious geographical distribution differences, while Chinese infants are dominated by enterotype
P.
There are also many types of probiotics, the main types are lactic acid bacteria and bifidobacteria; different types of probiotics have different genotypes, survival, tolerance, probiotic efficacy and adaptation to the population, which means that It is particularly important to select probiotics with similar genotypes and similar adaptations for health intervention
.
Strain resource protection and development: screening a batch of Chinese strains
Strain resources have always been the core of the probiotics industry, and it is also one of the difficult problems for domestic probiotics companies
.
At present, some probiotic companies in China have made breakthroughs in this regard
.
As a listed company in China's probiotics industry, Ketuo Biology attaches great importance to the development and utilization of bacterial resources
.
According to Dr.
Wang Jicheng, director of research and development of Ketuo Bio, since its establishment in 2003, Ketuo has cooperated with many domestic universities, research institutes and enterprises to collect natural fermented food, intestinal and breast milk samples from healthy people from all over Asia, and isolate and identify them.
And preserved 21268 strains of lactic acid bacteria, and built the largest strain library in Asia
.
It is not enough to have a strain library, which also requires scientific and accurate screening of the strains in it! Taking Ketuo Biology as an example, under the leadership of Chief Scientist Professor Zhang Heping, we overcame many difficulties and went through a lot of basic research including gene sequencing, safety evaluation, metabolomics analysis, etc.
, as well as follow-up animal experiments and clinical trials.
After waiting for research, we finally screened out a batch of probiotics from China, and applied for related patents! The most representative patented strains include Lactobacillus casei Zhang, Bifidobacterium lactis V9, Lactobacillus plantarum P-8; Bifidobacterium lactis Probio-M8 and Lactobacillus rhamnosus Probio-M8 from Chinese breast milk samples M9,
etc.
These precious strain resources not only create value and core competitiveness for enterprises, but also help the sustainable development of China's probiotics industry; under the background of changing lifestyles and declining strain resources, they have also preserved a number of valuable resources for the Chinese people.
The bacterial resources of the plant have laid a foundation for the development of more probiotics suitable for Chinese health in the future
.
What are high-quality probiotics: clinically proven safety and efficacy
High-quality probiotics must have undergone rigorous scientific research, including genetic background research, tolerance experiments, safety verification, industrial application evaluation, animal Experimental and most important clinical trial investigations
.
Ketuo Bio has also taken the lead in the research on probiotic efficacy.
At present, the research on star strains has been very detailed, and more than 300 documents have been published and more than 120 invention patents have been applied for
.
At present, Ketuo Bio has cooperated with more than ten tertiary hospitals in China, and has carried out a total of 60 clinical trials.
The clinical effects are remarkable and have won unanimous praise from doctors
.
In terms of the industrial application of probiotics, Ketuo Bio also attaches great importance to the research on probiotics that are more suitable for the Chinese intestines, and launched the Chinese intestinal system research project to establish the unique intestinal bacteria of the Chinese population.
Group database, relying on accurate Chinese people's intestinal flora data, has created a new "Yishiyou" product that better understands the Chinese people's intestines, has provided probiotic product support for more than 1,200 national team athletes, and provided preparations for 13 national teams.
.
Disclaimer: This article only represents the author's personal opinion and has nothing to do with China Probiotics Network
.
Its originality and the text and content stated in the text have not been verified by this site, and this site does not make any guarantee or commitment to the authenticity, completeness and timeliness of this text and all or part of its content and text.
Readers are only for reference and please Verify the relevant content yourself
.
Copyright Notice
1.
Some articles reproduced on this site are not original, and their copyright and responsibility belong to the original author
.
2.
All reprinted articles, links and pictures on this website are for the purpose of conveying more information, and the source and author are clearly indicated.
Media or individuals who do not wish to be reprinted can contact us for infringing information that can provide sufficient evidence.
, bio149 will be deleted within 12 hours after confirmation
.
3.
Users are welcome to submit original articles to 86371366@qq.
com, which will be published on the homepage after review, and the copyright and responsibility of the articles belong to the sender
.
As we all know, probiotics are important micro-ecological regulators, and long-term scientific research has confirmed that they can effectively regulate the human intestinal micro-ecology, and exert corresponding probiotic effects, which are beneficial to the human intestinal tract, immunity, metabolism and other fields.
health regulation
.
In recent years, probiotics have become an important choice for people seeking a healthy life
.
Choosing local probiotics that are more suitable for Chinese genes and dietary habits can better exert probiotic effects
.
Status quo of China's probiotics industry: the soil is weak and the ocean is strong.
Looking at the development of China's probiotics market for more than 20 years, there are still a series of problems such as a late start compared to foreign countries, weak independent research and development capabilities, and few patented strains; The safety verification and probiotic efficacy of "foreign bacteria" are fully researched, and they were listed in the Chinese market in large quantities earlier, which has resulted in the long-term dependence of the Chinese probiotic market on "foreign bacteria"
.
Scientific selection of probiotics: similar genotypes are more suitable
for this purpose.
Scientists have conducted large-scale scientific research, collecting samples from different countries (Korea, Japan, the United States, China), different races (America, Asia, Europe), and different diets.
The intestinal flora samples of the habitual population were tested for a series of indicators such as gene expression and metabolic level.
The results showed that different countries, ethnic dietary habits, living habits and even differences in metabolic levels all affect the differences in intestinal flora
.
This shows that there are significant differences in the intestinal flora of different populations, especially different continents and different national populations
.
There is also a comparative study on the intestinal flora of infants in different countries around the world, and found that there are significant differences in the intestinal flora of infants in different countries in the world.
The predominant P, A, and F enterotypes have obvious geographical distribution differences, while Chinese infants are dominated by enterotype
P.
There are also many types of probiotics, the main types are lactic acid bacteria and bifidobacteria; different types of probiotics have different genotypes, survival, tolerance, probiotic efficacy and adaptation to the population, which means that It is particularly important to select probiotics with similar genotypes and similar adaptations for health intervention
.
Strain resource protection and development: screening a batch of Chinese strains
Strain resources have always been the core of the probiotics industry, and it is also one of the difficult problems for domestic probiotics companies
.
At present, some probiotic companies in China have made breakthroughs in this regard
.
As a listed company in China's probiotics industry, Ketuo Biology attaches great importance to the development and utilization of bacterial resources
.
According to Dr.
Wang Jicheng, director of research and development of Ketuo Bio, since its establishment in 2003, Ketuo has cooperated with many domestic universities, research institutes and enterprises to collect natural fermented food, intestinal and breast milk samples from healthy people from all over Asia, and isolate and identify them.
And preserved 21268 strains of lactic acid bacteria, and built the largest strain library in Asia
.
It is not enough to have a strain library, which also requires scientific and accurate screening of the strains in it! Taking Ketuo Biology as an example, under the leadership of Chief Scientist Professor Zhang Heping, we overcame many difficulties and went through a lot of basic research including gene sequencing, safety evaluation, metabolomics analysis, etc.
, as well as follow-up animal experiments and clinical trials.
After waiting for research, we finally screened out a batch of probiotics from China, and applied for related patents! The most representative patented strains include Lactobacillus casei Zhang, Bifidobacterium lactis V9, Lactobacillus plantarum P-8; Bifidobacterium lactis Probio-M8 and Lactobacillus rhamnosus Probio-M8 from Chinese breast milk samples M9,
etc.
These precious strain resources not only create value and core competitiveness for enterprises, but also help the sustainable development of China's probiotics industry; under the background of changing lifestyles and declining strain resources, they have also preserved a number of valuable resources for the Chinese people.
The bacterial resources of the plant have laid a foundation for the development of more probiotics suitable for Chinese health in the future
.
What are high-quality probiotics: clinically proven safety and efficacy
High-quality probiotics must have undergone rigorous scientific research, including genetic background research, tolerance experiments, safety verification, industrial application evaluation, animal Experimental and most important clinical trial investigations
.
Ketuo Bio has also taken the lead in the research on probiotic efficacy.
At present, the research on star strains has been very detailed, and more than 300 documents have been published and more than 120 invention patents have been applied for
.
At present, Ketuo Bio has cooperated with more than ten tertiary hospitals in China, and has carried out a total of 60 clinical trials.
The clinical effects are remarkable and have won unanimous praise from doctors
.
In terms of the industrial application of probiotics, Ketuo Bio also attaches great importance to the research on probiotics that are more suitable for the Chinese intestines, and launched the Chinese intestinal system research project to establish the unique intestinal bacteria of the Chinese population.
Group database, relying on accurate Chinese people's intestinal flora data, has created a new "Yishiyou" product that better understands the Chinese people's intestines, has provided probiotic product support for more than 1,200 national team athletes, and provided preparations for 13 national teams.
.
Disclaimer: This article only represents the author's personal opinion and has nothing to do with China Probiotics Network
.
Its originality and the text and content stated in the text have not been verified by this site, and this site does not make any guarantee or commitment to the authenticity, completeness and timeliness of this text and all or part of its content and text.
Readers are only for reference and please Verify the relevant content yourself
.
Copyright Notice
1.
Some articles reproduced on this site are not original, and their copyright and responsibility belong to the original author
.
2.
All reprinted articles, links and pictures on this website are for the purpose of conveying more information, and the source and author are clearly indicated.
Media or individuals who do not wish to be reprinted can contact us for infringing information that can provide sufficient evidence.
, bio149 will be deleted within 12 hours after confirmation
.
3.
Users are welcome to submit original articles to 86371366@qq.
com, which will be published on the homepage after review, and the copyright and responsibility of the articles belong to the sender
.
As we all know, probiotics are important micro-ecological regulators, and long-term scientific research has confirmed that they can effectively regulate the human intestinal micro-ecology, and exert corresponding probiotic effects, which are beneficial to the human intestinal tract, immunity, metabolism and other fields.
health regulation
.
In recent years, probiotics have become an important choice for people seeking a healthy life
.
Choosing local probiotics that are more suitable for Chinese genes and dietary habits can better exert probiotic effects
.
Status quo of China's probiotics industry: the soil is weak and the ocean is strong.
Looking at the development of China's probiotics market for more than 20 years, there are still a series of problems such as a late start compared to foreign countries, weak independent research and development capabilities, and few patented strains; The safety verification and probiotic efficacy of "foreign bacteria" are fully researched, and they were listed in the Chinese market in large quantities earlier, which has resulted in the long-term dependence of the Chinese probiotic market on "foreign bacteria"
.
Scientific selection of probiotics: similar genotypes are more suitable
for this purpose.
Scientists have conducted large-scale scientific research, collecting samples from different countries (Korea, Japan, the United States, China), different races (America, Asia, Europe), and different diets.
The intestinal flora samples of the habitual population were tested for a series of indicators such as gene expression and metabolic level.
The results showed that different countries, ethnic dietary habits, living habits and even differences in metabolic levels all affect the differences in intestinal flora
.
This shows that there are significant differences in the intestinal flora of different populations, especially different continents and different national populations
.
There is also a comparative study on the intestinal flora of infants in different countries around the world, and found that there are significant differences in the intestinal flora of infants in different countries in the world.
The predominant P, A, and F enterotypes have obvious geographical distribution differences, while Chinese infants are dominated by enterotype
P.
There are also many types of probiotics, the main types are lactic acid bacteria and bifidobacteria; different types of probiotics have different genotypes, survival, tolerance, probiotic efficacy and adaptation to the population, which means that It is particularly important to select probiotics with similar genotypes and similar adaptations for health intervention
.
Strain resource protection and development: screening a batch of Chinese strains
Strain resources have always been the core of the probiotics industry, and it is also one of the difficult problems for domestic probiotics companies
.
At present, some probiotic companies in China have made breakthroughs in this regard
.
As a listed company in China's probiotics industry, Ketuo Biology attaches great importance to the development and utilization of bacterial resources
.
According to Dr.
Wang Jicheng, director of research and development of Ketuo Bio, since its establishment in 2003, Ketuo has cooperated with many domestic universities, research institutes and enterprises to collect natural fermented food, intestinal and breast milk samples from healthy people from all over Asia, and isolate and identify them.
And preserved 21268 strains of lactic acid bacteria, and built the largest strain library in Asia
.
It is not enough to have a strain library, which also requires scientific and accurate screening of the strains in it! Taking Ketuo Biology as an example, under the leadership of Chief Scientist Professor Zhang Heping, we overcame many difficulties and went through a lot of basic research including gene sequencing, safety evaluation, metabolomics analysis, etc.
, as well as follow-up animal experiments and clinical trials.
After waiting for research, we finally screened out a batch of probiotics from China, and applied for related patents! The most representative patented strains include Lactobacillus casei Zhang, Bifidobacterium lactis V9, Lactobacillus plantarum P-8; Bifidobacterium lactis Probio-M8 and Lactobacillus rhamnosus Probio-M8 from Chinese breast milk samples M9,
etc.
These precious strain resources not only create value and core competitiveness for enterprises, but also help the sustainable development of China's probiotics industry; under the background of changing lifestyles and declining strain resources, they have also preserved a number of valuable resources for the Chinese people.
The bacterial resources of the plant have laid a foundation for the development of more probiotics suitable for Chinese health in the future
.
What are high-quality probiotics: clinically proven safety and efficacy
High-quality probiotics must have undergone rigorous scientific research, including genetic background research, tolerance experiments, safety verification, industrial application evaluation, animal Experimental and most important clinical trial investigations
.
Ketuo Bio has also taken the lead in the research on probiotic efficacy.
At present, the research on star strains has been very detailed, and more than 300 documents have been published and more than 120 invention patents have been applied for
.
At present, Ketuo Bio has cooperated with more than ten tertiary hospitals in China, and has carried out a total of 60 clinical trials.
The clinical effects are remarkable and have won unanimous praise from doctors
.
In terms of the industrial application of probiotics, Ketuo Bio also attaches great importance to the research on probiotics that are more suitable for the Chinese intestines, and launched the Chinese intestinal system research project to establish the unique intestinal bacteria of the Chinese population.
Group database, relying on accurate Chinese people's intestinal flora data, has created a new "Yishiyou" product that better understands the Chinese people's intestines, has provided probiotic product support for more than 1,200 national team athletes, and provided preparations for 13 national teams.
.